株主資本合計、繰延税金負債、償却原価で測定する金融資産他1件
- 【期間】
| 年度 | 株主資本合計 | 繰延税金負債 | 償却原価で測定する金融資産 | 研究開発費 |
|---|
| 2007/03 | 1818億 | | - | | - | | - | |
| 2008/03 | 1852億 | +1.9% | 34.5億 | | - | | 29.6億 | |
| 2009/03 | 1826億 | -1.4% | 28.1億 | -18.6% | - | | 30.5億 | +2.9% |
| 2010/03 | 1663億 | -8.9% | 36.9億 | +31.4% | - | | 33.3億 | +9.4% |
| 2011/03 | 1782億 | +7.2% | 37.1億 | +0.5% | - | | 36.4億 | +9.2% |
| 2012/03 | 1890億 | +6% | 34.7億 | -6.4% | - | | 39億 | +7.1% |
| 2013/03 | 1937億 | +2.5% | 36.6億 | +5.4% | - | | 39.3億 | +0.8% |
| 2014/03 | 2067億 | +6.7% | 38.6億 | +5.5% | - | | 43.8億 | +11.3% |
| 2015/03 | 2237億 | +8.2% | 33.5億 | -13.3% | - | | 45億 | +2.8% |
| 2016/03 | 2303億 | +3% | 54.9億 | +64% | - | | 46億 | +2.3% |
| 2017/03 | 2418億 | +5% | 53.6億 | -2.4% | - | | 46.5億 | +1.1% |
| 2017/12 | 2557億 | +5.7% | 51.3億 | -4.2% | - | | 39.8億 | -14.4% |
| 2018/12 | 2818億 | +10.2% | 54.9億 | +7% | 7.72億 | | 51.5億 | +29.2% |
| 2019/12 | 2836億 | +0.6% | 55.5億 | +1.1% | 9.07億 | +17.5% | 51.8億 | +0.6% |
| 2020/12 | 2281億 | -19.6% | - | | 5.64億 | -37.8% | 47.4億 | -8.6% |
| 2021/12 | 2378億 | +4.3% | - | | 5.17億 | -8.3% | 50.7億 | +6.9% |
| 2022/12 | 2285億 | -3.9% | - | | 9.88億 | +91.1% | 58.6億 | +15.6% |
| 2023/12 | 2318億 | +1.4% | - | | 22.9億 | +131.9% | 56.2億 | -4.1% |
